UBS Maintains a 'Buy' on Walgreen (WAG); Downside Risk Priced In, Creating Favorable Risk/Reward Balance
Tweet
Share
E-mailGet Alerts WAG Hot Sheet
Price: $76.05 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
UBS maintains a 'Buy' on Walgreen (NYSE: WAG) price target raised $1 to $39.
Analyst, Jason DeRise, said, "WAG's Q2 12FY EPS was 1% above consensus, but 8% above our estimate. Q2 was always going to be a difficult quarter given it was the first quarter without Express Scripts (Nasdaq: ESRX). However, the company (1) grew front of store comp sales without heavy promotion and (2) managed SG&A costs effectively, minimizing the impact. This alleviates some market concern of a large EPS decline. We increase our 12FY EPS by ~3% accounting for the Q2 EPS beat as well a slight upgrade to H2 EPS. Our new EPS estimate declines -3% y/y." (FY12 EPS estimate raised from $2.48 to $2.56 and FY13 from $2.69 to $2.80)
For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.
Shares of Walgreen closed at $34.80 yesterday.
Analyst, Jason DeRise, said, "WAG's Q2 12FY EPS was 1% above consensus, but 8% above our estimate. Q2 was always going to be a difficult quarter given it was the first quarter without Express Scripts (Nasdaq: ESRX). However, the company (1) grew front of store comp sales without heavy promotion and (2) managed SG&A costs effectively, minimizing the impact. This alleviates some market concern of a large EPS decline. We increase our 12FY EPS by ~3% accounting for the Q2 EPS beat as well a slight upgrade to H2 EPS. Our new EPS estimate declines -3% y/y." (FY12 EPS estimate raised from $2.48 to $2.56 and FY13 from $2.69 to $2.80)
For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.
Shares of Walgreen closed at $34.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amazon.com (AMZN) PT Raised to $215 at UBS
- Chugai Pharmaceutical (4519:JP) PT Lowered to JPY5,200 at Nomura/Instinet
- Merck (MRK) PT Raised to $143 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
